Literature DB >> 17168876

A double-blind controlled study of a nonhydroquinone bleaching cream in the treatment of melasma.

Jean Luc Levy1, Fredéric Pons, Lise Agopian, Regis Besson.   

Abstract

BACKGROUND: Melasma is an acquired hypermelanosis predominantly affecting the face of women. It is often recalcitrant to treatment with hypopigmenting agents.
OBJECTIVE: To assess the efficacy of a nonhydroquinone cream (Amelan M) vs. another (Mela-D) as treatment for melasma.
METHODS: Twenty-two French women with bilateral epidermal and/or mixed melasma were enrolled in a split-faced prospective trial lasting 4 months during summer season weeks. Twelve patients applied once-daily Amelan M to one side of the face with sun-protective factor 60 UVA sunscreen each morning and Mela-D once-daily to the other side of the face. Pigmentation was measured objectively using a mexameter and the melasma area and severity index (MASI) were measured subjectively.
RESULTS: The mean decrease of pigmentation was statistically significant on the MASI with both cream and only with Amelan M with the mexameter. Some adverse side effects were observed.
CONCLUSIONS: Amelan M is really more effective than Mela D cream on melasma. Even though some side effects were observed patients preferred the Amelan M-treated side.

Entities:  

Year:  2005        PMID: 17168876     DOI: 10.1111/j.1473-2165.2005.00205.x

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  1 in total

1.  Solution of Azelaic Acid (20%), Resorcinol (10%) and Phytic Acid (6%) Versus Glycolic Acid (50%) Peeling Agent in the Treatment of Female Patients with Facial Melasma.

Authors:  Gita Faghihi; Azam Taheri; Zabihollah Shahmoradi; Mohammad Ali Nilforoushzadeh
Journal:  Adv Biomed Res       Date:  2017-02-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.